Prepared for IHR with AI assistance · Published October 10, 2026 · Medical review pending
Verify the investigator and team
Request current CVs, relevant experience, training and availability. FDA guidance addresses investigator qualifications and site adequacy. A profile alone cannot establish fit for a particular protocol.
Discuss supervision and safety
Clarify delegated responsibilities, investigator oversight and participant safety arrangements. FDA guidance emphasizes supervision, participant protection and data integrity. Ask for the evidence applicable to your study.
Turn capabilities into a documented plan
Our suggested discussion agenda includes equipment suitability, specimen logistics, staffing, language needs, recruitment assumptions and timelines. Agree a secure channel for documents. Do not interpret a website capability as an awarded study, enrollment guarantee or regulatory certification.
Sources and further reading
General education, not individualized medical advice or study consent. Official sources do not endorse IHR. Confirm all study-specific details with the research team.
Request feasibility discussion →